4,215
Views
7
CrossRef citations to date
0
Altmetric
Articles

Feasibility of robot-assisted radical prostatectomy in men at senior age ≥75 years: perioperative, functional, and oncological outcomes of a high-volume center

, , , , , , , , & show all
Pages 8-16 | Received 27 Sep 2021, Accepted 26 Nov 2021, Published online: 26 Dec 2021

References

  • Kontis V, Bennett JE, Mathers CD, et al. Future life expectancy in 35 industrialised countries: projections with a bayesian model ensemble. Lancet. 2017;389(10076):1323–1335.
  • Leyh-Bannurah SR, Karakiewicz PI, Pompe RS, et al. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations. World J Urol. 2018;37(3):469–479.
  • Reisz PA, Laviana AA, Zhao Z, et al. Assessing the quality of surgical care for clinically localized prostate cancer: results from the CEASAR study. J Urol. 2020;204(6):1236–1241.
  • Traboulsi SL, Nguyen DD, Zakaria AS, et al. Functional and perioperative outcomes in elderly men after robotic-assisted radical prostatectomy for prostate cancer. World J Urol. 2020;38(11):2791–2798.
  • Yamada Y, Teshima T, Fujimura T, et al. Comparison of perioperative outcomes in elderly (age > == 75 years) vs. younger men undergoing robot-assisted radical prostatectomy. PLOS One. 2020;15(6):e0234113.
  • Jang WS, Kim MS, Jeong WS, et al. Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases? BJU Int. 2018;121(2):225–231.
  • Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–262.
  • Dell'Oglio P, Zaffuto E, Boehm K, et al. Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer. Eur J Surg Oncol. 2017;43(8):1581–1588.
  • Ko YH. The comparison of the survival outcome between robotic-assisted radical prostatectomy and radiation therapy for localized prostate cancer in men over 70 years: Korean nationwide observational study. J Robot Surg. 2020;15(4):585–592.
  • Mandel P, Kriegmair MC, Kamphake J, et al. Tumor characteristics and oncologic outcome after radical prostatectomy in men 75 years old or older. J Urol. 2016;196(1):89–94.
  • Ryu JH, Kim SJ, Kim YB, et al. Radical prostatectomy for clinically localized prostate cancer in patients aged 75 years or older: comparison with primary androgen deprivation therapy. Aging Male. 2018;21(1):17–23.
  • Kumar A, Samavedi S, Bates AS, et al. Age stratified comparative analysis of perioperative, functional and oncologic outcomes in patients after robot assisted radical prostatectomy–a propensity score matched study. Eur J Surg Oncol. 2015;41(7):837–843.
  • Gurung PMS, Wang B, Hassig S, et al. Oncological and functional outcomes in patients over 70 years of age treated with robotic radical prostatectomy: a propensity-matched analysis. World J Urol. 2021;39(4):1131–1140.
  • Mandel P, Graefen M, Michl U, et al. The effect of age on functional outcomes after radical prostatectomy. Urol Oncol. 2015;33(5):203.e11-203–e18.
  • Nyarangi-Dix JN, Tosev G, Damgov I, et al. Recovery of pad-free continence in elderly men does not differ from younger men undergoing robot-assisted radical prostatectomy for aggressive prostate cancer. World J Urol. 2020;38(2):351–360.
  • Kastner C, Armitage J, Kimble A, et al. The charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis. 2006;9(3):270–274.
  • Hu JC. Comparative effectiveness of minimally invasive vs open radical prostatectomy. Jama. 2009;302(14):1557.
  • Gandaglia G, Sammon JD, Chang SL, et al. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol. 2014;32(14):1419–1426.
  • Leyh-Bannurah SR, Liakos N, Oelke M, et al. Perioperative and postoperative outcomes of robot-assisted radical prostatectomy in prostate cancer patients with prior transurethral subvesical deobstruction: results of a high-volume center. J Urol. 2021206(2):308–318.
  • Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–330.
  • Punnen S, Freedland SJ, Presti JC, Jr, et al. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol. 2014;65(6):1171–1177.
  • Droz J-P, Albrand G, Gillessen S, et al. Management of prostate cancer in elderly patients: recommendations of a task force of the international society of geriatric oncology. Eur Urol. 2017;72(4):521–531.
  • Fallara G, Sandin F, Styrke J, et al. Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scand J Urol. 2021;29:1–8.
  • Hoeh B, Preisser F, Mandel P, et al. Inverse stage migration in radical prostatectomy-A sustaining phenomenon. Front Surg. 2021;8:612813.
  • Leyh-Bannurah SR, Wagner C, Schuette A, et al. The impact of age on pathological insignificant prostate cancer rates in contemporary robot-assisted prostatectomy patients despite active surveillance eligibility. Minerva Urol Nephrol. 2021.doi:10.23736/S2724-6051.21.04174-4
  • Wenzel M, Wurnschimmel C, Chierigo F, et al. Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy. Prostate. 2021;81(11):728–735.
  • Isbarn H, Pinthus JH, Marks LS, et al. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol. 2009;56(1):48–56.
  • Yassin A, AlRumaihi K, Alzubaidi R, et al. Testosterone, testosterone therapy and prostate cancer. Aging Male. 2019;22(4):219–227.
  • Yassin A, Salman M, Talib RA, et al. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male. 2017;20(2):125–133.
  • Lu-Yao GL, Albertsen PC, Moore DF, et al. Fifteen-year outcomes following conservative management among men aged 65 years or older with localized prostate cancer. Eur Urol. 2015;68(5):805–811.
  • Rider JR, Sandin F, Andrén O, et al. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. European Urology. 2013;63(1):88–96.
  • Leyh-Bannurah SR, Zaffuto E, Dell'Oglio P, et al. Prediction of complications in radical prostatectomy prostate cancer patients: simulated annealing versus co-morbidity indexes. Urol Int. 2019;102(1):51–59.
  • Kawabuchi M, Tan H, Wang S. Age affects reciprocal cellular interactions in neuromuscular synapses following peripheral nerve injury. Ageing Res Rev. 2011;10(1):43–53.
  • Seppan P, Muhammed I, Mohanraj KG, et al. Therapeutic potential of mucuna pruriens (linn.) on ageing induced damage in dorsal nerve of the penis and its implication on erectile function: an experimental study using albino rats. Aging Male. 2020;23(5):313–326.
  • Verdú E, Ceballos D, Vilches JJ, et al. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst. 2000;5(4):191–208.
  • Fitzgerald M, McKelvey R. Nerve injury and neuropathic pain — a question of age. Exp Neurol. 2016;275:296–302.
  • Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'cologne male survey'. Int J Impot Res. 2000;12(6):305–311.
  • Hu JC, O'Malley P, Chughtai B, et al. Comparative effectiveness of cancer control and survival after robot-assisted versus open radical prostatectomy. J Urol. 2017;197(1):115–121.
  • Molina-Garrido MJ, Guillen-Ponce C. Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review. Aging Male. 2017;20(2):102–109.